From December 3–5, Sydney will host the 9th Asian Federation for Pharmaceutical Sciences (AFPS) Conference, a leading forum for pharmaceutical scientists, industry experts, regulators, and academics from across Asia and beyond.
This year’s program will feature the launch of the Asian Pediatric Formulation Initiative (PFI), a new platform to advance age-appropriate medicines for children in the region—an area where Fagron brings proven expertise.
Fagron will contribute to the scientific program with the presentation Bridging Unmet Needs in Pediatric Pharmacotherapy: Scientific Advances in Personalized, Age-Appropriate Formulations, highlighting our innovative work with SyrSpend®, DiluCap®, and OrPhyllo™.
With themes ranging from AI-driven drug discovery and advanced drug delivery to pediatric taste-masking and formulation design, AFPS 2025 is an ideal stage to share our knowledge, connect with key stakeholders, and strengthen our presence in the APAC region.
